A 10-year prognostic study of CTEPH patients showed that worse final NYHA FC, inoperability, lower 6MWD at follow-up, higher NT-proBNP at follow-up, and reduced TAPSE are prognostic markers of poor outcomes of CTEPH patients (18). Here, NPPB is linked to chronic thromboembolic pulmonary hypertension.